Pharmaceutical Technology Europe (ISSN 0164-6826) is a journal published by Advanstar Communications Inc. in the United States. It covers Pharmacology, Toxicology and Pharmaceutics and Pharmaceutical Science. It is indexed in Scopus and HEC. Recorded metrics: Scopus Q4, CiteScore 0.1 and HEC Y-Category. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, Scopus data, SJR and SCImago rank, indexing, open access status, aims and scope, about the journal, author instructions, journal website and registration details from the most reputable indexes, in one place.
Pharmaceutical Technology Europe
Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.
Journal lists: Q4 journals · HEC Y category journals · Scopus journals · SCImago journals
Quick answers about Pharmaceutical Technology Europe
Is Pharmaceutical Technology Europe HEC recognised?
Yes. The catalogue records Pharmaceutical Technology Europe in HEC category Y of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.
Is Pharmaceutical Technology Europe indexed in Scopus?
Yes. Pharmaceutical Technology Europe is listed as Scopus-indexed, in quartile Q4, with a CiteScore of 0.1. Check its current status on the Scopus Sources page.
Is Pharmaceutical Technology Europe in Web of Science?
Pharmaceutical Technology Europe is not listed as a Web of Science journal in this record. Confirm on Clarivate's Master Journal List.
Is Pharmaceutical Technology Europe open access, and what does it charge?
Pharmaceutical Technology Europe is not recorded as fully open access. Fees change, so check the journal's website before you submit.
Who publishes Pharmaceutical Technology Europe?
Pharmaceutical Technology Europe is published by Advanstar Communications Inc. in United States, under ISSN 0164-6826.